Proteome Sciences plc (LON:PRM – Get Free Report)’s share price rose 11.4% during mid-day trading on Friday . The stock traded as high as GBX 5 ($0.06) and last traded at GBX 5 ($0.06). Approximately 234,559 shares traded hands during trading, an increase of 33% from the average daily volume of 176,457 shares. The stock had previously closed at GBX 4.49 ($0.06).
Proteome Sciences Price Performance
The company has a debt-to-equity ratio of -258.66, a quick ratio of 0.37 and a current ratio of 0.20. The company has a market capitalization of £14.37 million, a PE ratio of -3.52 and a beta of 0.07. The company’s 50-day simple moving average is GBX 3.89 and its 200-day simple moving average is GBX 3.27.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Further Reading
- Five stocks we like better than Proteome Sciences
- NYSE Stocks Give Investors a Variety of Quality Options
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- 3 Dividend Kings To Consider
- DuPont’s Electronics Spinoff: The Start of Something Big
- What Makes a Stock a Good Dividend Stock?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
